Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026
Moderna (NASDAQ:MRNA) will hold a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results and provide a corporate update.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Moderna (NASDAQ:MRNA) will hold a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results and provide a corporate update.
The live and archived webcasts will be available in the Investors section of Moderna's website.
Details
Market move: MRNA +3.74% in the Jul 9 session. 2Q26 earnings date
On Jul 9, the day this news came out, MRNA closed 3.74% above the previous close. Our momentum scanner recorded 2 alerts for this stock that day.
Data tracked by StockTitan Argus for the Jul 9 session.
Key Figures
- Earnings call time
- 8:00 a.m. ET
- Second quarter 2026 results call on July 31, 2026
- Earnings date
- July 31, 2026
- Scheduled second quarter 2026 financial results release
- Archive delay
- 2 hours
- Approximate time after call before webcast archive is posted
- Archive duration
- 1 year
- Length of time archived webcast will remain available
Previous Earnings date Reports
-
Scheduled release of first quarter 2026 results with 8:00 a.m. ET call.
-
Announced date and time for fourth quarter 2025 earnings call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Friday, July 31, 2026 to report its second quarter 2026 financial results, and provide a corporate update.
A live webcast of the call will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: https://investors.modernatx.com
The archived webcast will be available on Moderna's website approximately two hours after the conference call and will be available for one year following the call.
About Moderna
Moderna is a pioneer and leader in the field of mRNA medicine. Through the advancement of its technology platform, Moderna is reimagining how medicines are made to transform how we treat and prevent diseases. Since its founding, Moderna's mRNA platform has enabled the development of vaccines and therapeutics across infectious diseases, cancer, rare diseases and more.
With a global team and a unique culture, driven by the company's values and mindsets, Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.